Implementation of an innovative laser CO2 system for the treatment of aesthetic gynaecology and the treatment of incontinence in Femicare Magdalena Czyżaz w Grudziądz. (Q97980): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: EU contribution (P835): 34,224.379199999996 euro) |
(Changed an Item: Fixing rounding issue) |
||||||||||||||
Property / EU contribution | |||||||||||||||
34,224.38 Euro
| |||||||||||||||
Property / EU contribution: 34,224.38 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution: 34,224.38 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.24 Euro
| |||||||||||||||
Property / EU contribution: 34,224.38 Euro / qualifier | |||||||||||||||
point in time: 13 January 2020
|
Revision as of 21:06, 23 September 2020
Project in Poland financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | Implementation of an innovative laser CO2 system for the treatment of aesthetic gynaecology and the treatment of incontinence in Femicare Magdalena Czyżaz w Grudziądz. |
Project in Poland financed by DG Regio |
Statements
142,601.58 zloty
0 references
259,275.6 zloty
0 references
55.0 percent
0 references
30 March 2017
0 references
31 January 2018
0 references
FEMICARE MAGDALENA CZYŻO
0 references
Wnioskodawca poprzez realizacje projektu pragnie wdrożyć innowacyjną technologie leczenia nietrzymania moczu. Wdrożenie technologii odbędzie się w wyniku zakupu systemu laserowego CO2 SMARTXIDE. (Polish)
0 references
The applicant wishes to implement innovative technologies in the treatment of incontinence. The technology will be implemented as a result of the purchase of a CO2 SMARXIDE laser system. (English)
0 references
Identifiers
RPKP.01.06.02-04-0069/16
0 references